CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 1,19 · Q1 • database Scopus / SJR & Web of Science indexed
Drug Design, Development and Therapy
New Zealand · Dove Medical Press Ltd
workspace_premium Q1 — Drug Discovery visibility_off Single blind Peer Review lock_open Open Access

Drug Design, Development and Therapy

Drug Design, Development and Therapy is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 108. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on drug design, drug safety, drug development, pharmaecuticals. It has an SJR impact factor of 1,19 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,19.

Drug Design, Development and Therapy focuses its scope in these topics and keywords: brain, signaling, treatment, apoptosis, pathway, ovarian, nuclear, induced, factor, breast, ...

Publisher: Dove Medical Press Ltd
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,19 Q1
H-index 108
Acceptance rate pie_chart
27% Selective
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.079 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,19

H-index

108

Docs (year)

426

Docs 3y

947

Total refs

24840

Cites 3y

5610

Citable 3y

929

Cites/Doc 2y

5.23

Ref/Doc

58.31

Immediate OA

2079 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Drug Design, Development and Therapy?

Drug Design, Development and Therapy has an SJR of 1,19 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 2079 EUR.

What is the acceptance rate?

The acceptance rate recorded for Drug Design, Development and Therapy is 27%.